gms | German Medical Science

14th Triennial Congress of the International Federation of Societies for Surgery of the Hand (IFSSH), 11th Triennial Congress of the International Federation of Societies for Hand Therapy (IFSHT)

17.06. - 21.06.2019, Berlin

Article

Send article

Hand therapy or not following collagenase treatment for Dupuytren’s contracture? The protocol of a randomised controlled trial

Meeting Abstract

Search Medline for

  • presenting/speaker Terese Aglen - Haukeland University Hospital, Department of Occupational Therapy, Orthopaedic Clinic, Bergen, Norway
  • Karin Hoegh Matre - Haukeland University Hospital, Department of Occupational Therapy, Orthopaedic Clinic, Bergen, Norway
  • Ruud W. Selles - Erasmus MC University Medical Center, Department of Rehabilitation Medicine and department, Department of Hand Surgery, Rotterdam, Netherlands
  • Jörg Aßmus - Haukeland University Hospital, Centre for Clinical Research, Bergen, Norway
  • Tina Taule - Haukeland University Hospital, Department of Occupational Therapy, Orthopaedic Clinic, Bergen, Norway

International Federation of Societies for Surgery of the Hand. International Federation of Societies for Hand Therapy. 14th Triennial Congress of the International Federation of Societies for Surgery of the Hand (IFSSH), 11th Triennial Congress of the International Federation of Societies for Hand Therapy (IFSHT), 11th Triennial Congress of the International Federation of Societies for Hand Therapy (IFSHT). Berlin, 17.-21.06.2019. Düsseldorf: German Medical Science GMS Publishing House; 2020. DocIFSHT19-1215

doi: 10.3205/19ifssh1516, urn:nbn:de:0183-19ifssh15160

Published: February 6, 2020

© 2020 Aglen et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.

Outline

Text

Objective: Knowledge about hand therapy post collagenase treatment for Dupuytren's contracture (DC) is limited. The main purpose of this study is to determine if hand therapy improves patients' performance of and satisfaction with everyday activities. Differences between patients with contracted proximal interphalangeal joints (PIPJ) and patients with affected metacarpophalangeal joints (MCPJ) only, will also be investigated.

Materials and Methods: A randomised controlled trial will be conducted with two parallel intervention groups in a pretest-posttest design. Each group will contain two equal-sized subgroups; one with MCPJ contracted solely, and one with PIPJ contracture involved. Patients treated with collagenase for DC are eligible. Exclusion criteria are earlier injury or treatment for DC in the same finger. Participants will be randomised to receive either hand therapy or no therapy. Hand therapy includes scar management, splinting, movement exercises and everyday activities. Main outcome is patients' performance of and satisfaction with everyday activities using the Canadian Occupational Performance Measure. Secondary outcome measures are DC related everyday activities using URAM scale, active/passive flexion/extension of treated joints using a goniometer, grip force using Jamar dynamometer and pain using a Visual Analogue Scale. Demographical and medical variables, scarring, cold hypersensitivity, sick-leave and satisfaction with the result will be registered. Test times are right before, six weeks, four months and one year following collagenase treatment. The required sample size is 160 participants. Appropriate methods of statistical analysis will be used.

Results: When the study has been completed, the results will be sent as an article to an appropriate scientific journal.

Conclusions: The study will provide a basis to determine whether or not hand therapy should be offered after collagenase treatment for DC.